BRD2 and lymphoma: Among 67 evaluable lymphoma female patients treated with alkylating agents between 2002 and 2008, COF (defined as at least one measurement of FSH level >40 IU/L) occurred in 19.5 and 25% of patients in the triptorelin and control arm respectively.